Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
60.33
-0.77 (-1.26%)
Streaming Delayed Price
Updated: 10:59 AM EDT, Apr 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,187,423
Open
60.23
Bid (Size)
60.32 (400)
Ask (Size)
60.34 (200)
Prev. Close
61.10
Today's Range
59.88 - 60.58
52wk Range
42.52 - 62.89
Shares Outstanding
2,222,113,553
Dividend Yield
4.18%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Trillion-Dollar Treatment: A Deep Dive into Eli Lilly and Company (LLY)
Today 9:41 EDT
As of April 2, 2026, Eli Lilly and Company (NYSE:LLY) stands as the preeminent titan of the global healthcare sector. Historically recognized as a steady, century-old pharmaceutical giant, the company...
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
3 Value Stocks Walking a Fine Line
Today 0:37 EDT
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Via
StockStory
Performance
YTD
+12.9%
+12.9%
1 Month
-3.2%
-3.2%
3 Month
+11.8%
+11.8%
6 Month
+27.2%
+27.2%
1 Year
+1.3%
+1.3%
More News
Read More
Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability
March 31, 2026
Via
Finterra
Topics
Initial Public Offering
United Therapeutics Surges 14% on Groundbreaking Tyvaso Phase 3 Results for IPF
March 31, 2026
Via
MarketMinute
Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in Multiple Myeloma as Program Marks Ten Years
March 31, 2026
From
Bristol Myers Squibb
Via
Business Wire
1 Surging Stock with Impressive Fundamentals and 2 That Underwhelm
March 30, 2026
Via
StockStory
Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
March 29, 2026
From
Bristol Myers Squibb
Via
Business Wire
Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy™ (xanomeline and trospium chloride)
March 28, 2026
From
Bristol Myers Squibb
Via
Business Wire
MarketMinute: Corcept Therapeutics (CORT) Surges 19.66% on Surprise FDA Approval and Oncology Breakthrough
March 26, 2026
Via
MarketMinute
Topics
Intellectual Property
Stocks making big moves yesterday: Robinhood, Payoneer, Micron, Limbach, and Bristol-Myers Squibb
March 26, 2026
Via
StockStory
Firing on All Cylinders: Eli Lilly (NYSE:LLY) Q4 Earnings Lead the Way
March 25, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Why Bristol-Myers Squibb (BMY) Stock Is Up Today
March 25, 2026
Via
StockStory
Topics
Artificial Intelligence
Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience
March 25, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
What Is Considered a Good Stock Dividend? 2 Healthcare Stocks Fit the Bill.
↗
March 24, 2026
Via
The Motley Fool
Topics
Intellectual Property
Bristol-Myers Squibb Shares Jump 3.3% on Robust 2026 Guidance and High Dividend Yield
March 23, 2026
Via
MarketMinute
Topics
Economy
Initial Public Offering
Intellectual Property
Should You Buy Bristol Myers Squibb Stock for Its 4.4%-Yielding Dividend?
↗
March 23, 2026
Via
The Motley Fool
Topics
Intellectual Property
FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market
March 23, 2026
Via
MarketMinute
Bristol Myers Squibb Reinforces Leadership in oHCM with New Camzyos (mavacamten) Data at American College of Cardiology Annual Scientific Session & Expo 2026 (ACC.26)
March 23, 2026
From
Bristol Myers Squibb
Via
Business Wire
1 High-Yield Dividend Stock That's Too Cheap to Ignore
↗
March 21, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab)
March 20, 2026
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026
March 19, 2026
From
Bristol Myers Squibb
Via
Business Wire
AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown
March 18, 2026
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
Bristol‑Myers Squibb: The Boring Dividend Stock I'd Happily Hold Through Any Crash
↗
March 18, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
READYSTATE Dumps 361,000 Workiva Shares Worth $32 Million
↗
March 17, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
The Grand Divergence: Finance Surges as Health Care Braces for a Historic Q1 Earnings Slump
March 17, 2026
Via
MarketMinute
Topics
Earnings
Economy
Initial Public Offering
Frequently Asked Questions
Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 60.33
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 04/02/26 10:59 AM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 134.06B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 134B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.